Xenon Pharmaceuticals Inc. (XENE)
NASDAQ: XENE · Real-Time Price · USD
62.76
+20.82 (49.64%)
At close: Mar 9, 2026, 4:00 PM EDT
62.45
-0.31 (-0.49%)
After-hours: Mar 9, 2026, 7:59 PM EDT

Xenon Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
5,2213,4632,9893,5032,4661,643
Upgrade
Market Cap Growth
73.90%15.89%-14.68%42.03%50.06%196.62%
Upgrade
Enterprise Value
4,6432,9172,1952,8751,7211,397
Upgrade
Last Close Price
62.7644.8239.2046.0639.4331.24
Upgrade
PS Ratio
696.14461.80--261.4189.14
Upgrade
PB Ratio
8.635.953.963.783.422.99
Upgrade
P/TBV Ratio
8.975.953.963.783.422.99
Upgrade
PEG Ratio
-2.512.512.512.512.51
Upgrade
EV/Sales Ratio
619.06388.87--182.4475.77
Upgrade
Debt / Equity Ratio
0.010.010.010.010.010.02
Upgrade
Net Debt / Equity Ratio
-0.99-0.99-0.99-0.99-0.98-0.99
Upgrade
Net Debt / EBITDA Ratio
1.561.562.694.345.566.96
Upgrade
Net Debt / FCF Ratio
2.072.074.045.876.847.60
Upgrade
Asset Turnover
0.010.01--0.010.05
Upgrade
Quick Ratio
13.1713.1717.6623.4326.1238.72
Upgrade
Current Ratio
13.4213.4217.8523.6526.4439.03
Upgrade
Return on Equity (ROE)
-51.76%-51.76%-27.85%-22.12%-19.72%-21.87%
Upgrade
Return on Assets (ROA)
-32.58%-32.58%-19.80%-15.57%-12.17%-12.97%
Upgrade
Return on Capital Employed (ROCE)
-63.10%-63.10%-36.60%-22.80%-17.70%-14.20%
Upgrade
Earnings Yield
-6.63%-9.99%-7.84%-5.21%-5.08%-4.80%
Upgrade
FCF Yield
-5.36%-8.08%-6.17%-4.47%-4.21%-4.35%
Upgrade
Buyback Yield / Dilution
-1.75%-1.75%-16.45%-10.48%-38.77%-21.09%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.